A prospective study to determine the clinical utility of pharmacogenetic testing of veterans with treatment-resistant depression. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

A prospective study to determine the clinical utility of pharmacogenetic testing of veterans with treatment-resistant depression.

McCarthy MJ, Chen Y, Demodena A, Leckband SG, Fischer E, Golshan S, Suppes T, Kelsoe JR. A prospective study to determine the clinical utility of pharmacogenetic testing of veterans with treatment-resistant depression. J Psychopharmacol. 2021 Aug; 35(8):992-1002.

View in: PubMed

authors with profiles

Michael McCarthy

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support